YIG-CCA

Young Investigator Group of EURO-CHOLANGIO-NET Cost Action

[EASLnews @EASLnews]

Let's build the future of hepatology together! 🤝

We are currently looking for:
- 3 Scientific Committee Members
- 4 Educational Committee Members
- 2 Policy, Public Health, and Advocacy Committee Members
- 3 Young Investigator Task Force members
- 1 Nurses & AHPs Task Force member

Read more and apply: https://t.co/nGLE69fwNo

[Ana Lleo @analleo]

🆘 CCA is a deadly cancer
🧬 preclinical research is key!

🆕 CCA-on-a-chip model just published in ⁦@JHEP_Reports⁩ ⁦@EASLnews⁩

🙏🏻support ⁦⁦@AIRC_it⁩
⁦@HUNIMED⁩ ⁦@polimi⁩ ⁦@RasponiMarco⁩ ⁦⁦@MichelaPolid⁩ https://t.co/cFs4vHtSoS

[ccauk @ccaukgroup]

Abstract submission and registration now open for the CCA-UK National Meeting on 2nd Feb 2024.
Further information, including a draft programme can be found here -https://t.co/pjOkSYFE2f…

#cholangiocarcinoma #bileductcancer #CCAUK2024

[HPB Dublin @HPBDublin]

Wonderful opportunity to join our stellar HPB & Transplant unit in Dublin @svuh

🟢2 Yr Fully-Funded & Accredited Fellowship
🟢Significant Operative Experience
🟢Research Opportunities
🟢Just in time for #eahpba2025 Dublin!

@SurgerySvhg @EAHPBA @IHPBA

https://t.co/s2UxrIoWjY

[Pharmacology Valencia @pharmacologyvlc]

LAST DAY to register for the 2nd International Workshop on Liver and Gut Fibrosis. See you in VALENCIA, 26-27 Oct! https://t.co/MNf7zNJIum #IBD #crohns #Fibrosis #livertwitter @Y_ECCO_IBD @aegastro @CIBERehd
@ueg @UV_EG @GVAfisabio

[Pilar Acedo @pilar_acedo]

Still recovering from #UEGWeek... What an amazing Congress! Thanks @my_ueg Community for everything, including Let's Meet & UEG Night 😉 and my Rising 🌟Award! Looking forward to #UEGWeek2024 in Vienna!

[EASL Education @EASLedu]

Join us this week for an #EASLStudio Replay !

Albumin in #cirrhosis: for all, some, or none?😕❓
📅25 October at 18:00 CET
🔗https://t.co/HYqa8wxfpv

@EASLnews @AleksanderKrag @ThomasBerg24
@RajivJalan1 @aelsharkawy75 @rabataller

[Flavio G Rocha, MD, FACS, FSSO @FlavioRochaMD]

@curecc CEO @staclinds presenting the Keynote Report 🔑 📝 at #CCA2023 from #Cholangiocarcinoma Foundation.

So much has been achieved since 2006 but more needs to be done.

Already looking forward to #ccfac2024

#advocacy #clinicaltrials #multiDcare

[Angela Lamarca @DrAngelaLamarca]

Studies exploring #Cabozantinib in #NET

2/2 — CABINET (cabo vs placebo) by #JenniferChan

Phase III; epNET and pNET cohorts. Early closure due to “compelling efficacy”

#PFS benefit in BOTH cohorts! HR 0.45 epNET and HR 0.27 pNET 🔝🔝🔝

💪New option? (my vote -YES!)

@myESMO

[jorge_adeva_MD @cofiadeva]

@DrAngelaLamarca gives a brilliant review by about immunotherapy in BTC.
👉1st L --> aPDL1/PD1 + Cisgem is clearly SOC
❓️Keep QT (Gem) after 6 months along with IO? 
🗨STOP cisgem after 6 months. Keep IO alone.
🗨We need biomarkers!
🗨Our patients need to have this SOC now!

[EASLnews @EASLnews]

Young Investigators of #LiverTwitter, how do you interpret liver biopsies?🤔

Now's the chance to sharpen your skills with this dedicated upcoming #EASLSchool, taking place 12-13 April 2024 in @hospitalclinic 🇪🇸 with experts Alba Díaz & Xavier Forns!

Read more & register now by 15 Oct on https://t.co/tc4UWA3neU

[EURO-CHOLANGIO-NET @CholangioNet]

The EURO-CHOLANGIO-NET, @CcaEns and ICRN are proud to announce the new mentorship lecture!
➡️"WOMEN IN SCIENCES: PASSION AND CHALLENGES"
🎙️@fouassier_lab
🗓️21 September, 3PM CET, 9AM EST
✏️Learn more and register here:
https://t.co/0DCSeWs8rU

[EASLnews @EASLnews]

📣 Calling all our young investigators on #LiverTwitter! It's already back to School in 2024🔥

Discover our four EASL Schools, pick the one you are interested in, and apply today!

Read more on: https://t.co/0C4WzQ0uRy

@EASLedu @AleksanderKrag @DebbieShawcros1 @aelsharkawy75

[Cholangiocarcinoma Foundation @curecc]

We invite you to participate in a survey to help understand the challenges of dealing with cancer and cancer treatment and how those realities affect your quality of life.

For more information and to take the survey, please visit https://t.co/JDejQDWLcb.

[JHEP Reports @JHEP_Reports]

Long-term follow-up of patients discontinuing #bulevirtide treatment upon long-term #HDV-RNA suppression

🔓#OpenAccess at👉https://t.co/eda1vUXLnT

@mathiasjachs
@ReibergerThomas
#LiverTwitter

[EURO-CHOLANGIO-NET @CholangioNet]

📢EURO-CHOLANGIO-NET is looking for MSCA applicants!🧑‍🎓

👉Please check our YouTube channel https://t.co/m2t40XTgY0 & share with anyone who might be interested!🙋

@EASLnews @EASLedu @my_ueg @AASLDtweets @CCA_Alliance @rirmacias @chiaragabbi1 @CharityAMMF @ResearchCureCCA

[FASEB @FASEBorg]

We've got an amazing program planned for this exciting conference on a rare but virulent form of bile duct cancer. This is a first-of-its-kind event for researchers so don't miss it! #CHOSRC @MarioStrazzabos @SumeraIlyasMD
View the program: https://t.co/Z2YDpOxPvO

[Jordi Gracia-Sancho @JSGracia]

Join us through this excellent funding opportunity!

👩🏼‍🔬👨🏽‍⚕️👨🏻‍💻Multidisciplinary team coordinated by @mromerogomez @CUBEROlab and 🙋🏻‍♂️

🔬 Topic: Steatotic liver disease from bench to bedside, and viceversa

🏙️ 3 labs in 3 years ‼️

All info: https://t.co/sZB70zOQUC

🫶🏼 Please RT 🫶🏼

[EASLnews @EASLnews]

⏰Last call for applications to join the EASL Scientific Committee!
Deadline: Tomorrow, 15 August (23:59 CEST)
Read more & apply now: https://t.co/7f1BASPkwf

@AleksanderKrag @DebbieShawcros1 @RuiCastroHD @VirginiaHdezGea @analleo @NaultJc @etrepo @aelsharkawy75 @fprusso73

[Helen Morement @HelenMorement]

Pleased to have been part of UK NHSBT Transplantation for CCA FTW Group! The outcome - a pilot transplant programme for iCCA. Stringent eligibility criteria but this represents a 1st & important step forward. See paper: https://t.co/AiQOk6KjUH
#LiverTwitter #cholangiocarcinoma